|
JPH0329734A
(ja)
|
1989-06-20 |
1991-02-07 |
Kubota Corp |
ラベルプリンタ
|
|
GB9600384D0
(en)
|
1996-01-09 |
1996-03-13 |
Nyfotek As |
Dna glycosylases
|
|
US6886207B1
(en)
|
1999-06-14 |
2005-05-03 |
The Procter & Gamble Company |
Toothbrush
|
|
CA2392490A1
(en)
|
1999-11-24 |
2001-05-31 |
Mcs Micro Carrier Systems Gmbh |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
US20040003420A1
(en)
|
2000-11-10 |
2004-01-01 |
Ralf Kuhn |
Modified recombinase
|
|
US20050222030A1
(en)
|
2001-02-21 |
2005-10-06 |
Anthony Allison |
Modified annexin proteins and methods for preventing thrombosis
|
|
EP1392846B1
(en)
|
2001-02-27 |
2008-06-11 |
University of Rochester |
METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING
|
|
AU2002330714A1
(en)
|
2001-05-30 |
2003-01-02 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
US7300829B2
(en)
|
2003-06-02 |
2007-11-27 |
Applied Materials, Inc. |
Low temperature process for TFT fabrication
|
|
WO2010132092A2
(en)
|
2009-05-12 |
2010-11-18 |
The Scripps Research Institute |
Cytidine deaminase fusions and related methods
|
|
US20110104787A1
(en)
|
2009-11-05 |
2011-05-05 |
President And Fellows Of Harvard College |
Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
|
|
JP2013514779A
(ja)
|
2009-12-18 |
2013-05-02 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
脱メチル化および細胞の再プログラミングを促進するためのシチジンデアミナーゼ関連薬剤の使用
|
|
ES2618632T3
(es)
|
2011-09-28 |
2017-06-21 |
Zera Intein Protein Solutions, S.L. |
Inteínas divididas y usos de éstas
|
|
CN103088008B
(zh)
|
2011-10-31 |
2014-08-20 |
中国科学院微生物研究所 |
胞苷脱氨酶及其编码基因和它们的应用
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
LT3401400T
(lt)
|
2012-05-25 |
2019-06-10 |
The Regents Of The University Of California |
Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
|
|
US9102936B2
(en)
|
2012-06-11 |
2015-08-11 |
Agilent Technologies, Inc. |
Method of adaptor-dimer subtraction using a CRISPR CAS6 protein
|
|
AU2013280693B2
(en)
|
2012-06-27 |
2018-01-04 |
The Trustees Of Princeton University |
Split inteins, conjugates and uses thereof
|
|
EP3135765A1
(en)
|
2012-12-06 |
2017-03-01 |
Sigma-Aldrich Co. LLC |
Crispr-based genome modification and regulation
|
|
EP2931898B1
(en)
|
2012-12-12 |
2016-03-09 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
RS63798B1
(sr)
|
2013-05-13 |
2022-12-30 |
Cellectis |
Cd19 specifični himerni antigenski receptor i njegove primene
|
|
WO2014186686A2
(en)
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
|
US20140356956A1
(en)
|
2013-06-04 |
2014-12-04 |
President And Fellows Of Harvard College |
RNA-Guided Transcriptional Regulation
|
|
BR112016000571B1
(pt)
|
2013-07-10 |
2023-12-26 |
President And Fellows Of Harvard College |
Métodos in vitro para modular a expressão e para alterar um ou mais ácidos nucleicos alvo em uma célula simultaneamente com a regulação da expressão de um ou mais ácidos nucleicos alvo em uma célula, bem como célula de levedura ou bactéria compreendendo ácidos nucleicos
|
|
US20150044772A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
Crispr/cas system-based novel fusion protein and its applications in genome editing
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
EP3835419A1
(en)
|
2013-12-12 |
2021-06-16 |
The Regents of The University of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
|
WO2015089486A2
(en)
*
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
|
CA2931684C
(en)
|
2013-12-19 |
2024-02-20 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
|
WO2015092024A2
(en)
|
2013-12-20 |
2015-06-25 |
Cellectis |
Method of engineering multi-input signal sensitive t cell for immunotherapy
|
|
EP3115457B1
(en)
|
2014-03-05 |
2019-10-02 |
National University Corporation Kobe University |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
AU2015289644A1
(en)
|
2014-07-15 |
2017-02-02 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
JP2017522893A
(ja)
|
2014-07-31 |
2017-08-17 |
セレクティスＣｅｌｌｅｃｔｉｓ |
Ｒｏｒ１特異的多重鎖キメラ抗原受容体
|
|
US10450584B2
(en)
|
2014-08-28 |
2019-10-22 |
North Carolina State University |
Cas9 proteins and guiding features for DNA targeting and genome editing
|
|
BR112017007765B1
(pt)
|
2014-10-14 |
2023-10-03 |
Halozyme, Inc |
Composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo
|
|
WO2016061368A1
(en)
|
2014-10-15 |
2016-04-21 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treating b-lymphoid malignancies
|
|
EP3212221B1
(en)
|
2014-10-29 |
2023-12-06 |
Massachusetts Eye & Ear Infirmary |
Efficient delivery of therapeutic molecules in vitro and in vivo
|
|
EP3216867B1
(en)
|
2014-11-04 |
2020-04-15 |
National University Corporation Kobe University |
Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
|
|
MA40921A
(fr)
|
2014-11-05 |
2017-09-12 |
Abbvie Stemcentrx Llc |
Récepteurs antigéniques chimériques anti-cldn et procédés d'utilisation
|
|
US11072644B2
(en)
|
2014-11-12 |
2021-07-27 |
Allogene Therapeutics, Inc. |
Inhibitory chimeric antigen receptors
|
|
EP3971210A1
(en)
|
2014-12-12 |
2022-03-23 |
2seventy bio, Inc. |
Composition for use in the treatment of b cell related conditions in a subject in need thereof comprisine an effector cell comrising a bcma chimeric antigen receptors
|
|
EP3957745A1
(en)
*
|
2014-12-20 |
2022-02-23 |
Arc Bio, LLC |
Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins
|
|
US11180792B2
(en)
*
|
2015-01-28 |
2021-11-23 |
The Regents Of The University Of California |
Methods and compositions for labeling a single-stranded target nucleic acid
|
|
MA41613A
(fr)
|
2015-02-23 |
2018-01-02 |
Abbvie Stemcentrx Llc |
Récepteurs antigéniques chimériques anti-dll3 et procédés d'utilisation desdits récepteurs
|
|
WO2016142532A1
(en)
|
2015-03-11 |
2016-09-15 |
Cellectis |
Methods for engineering allogeneic t cell to increase their persistence and/or engraftment into patients
|
|
EP3286571B1
(en)
|
2015-04-24 |
2021-08-18 |
Editas Medicine, Inc. |
Evaluation of cas9 molecule/guide rna molecule complexes
|
|
US20180291372A1
(en)
|
2015-05-14 |
2018-10-11 |
Massachusetts Institute Of Technology |
Self-targeting genome editing system
|
|
MA43344A
(fr)
|
2015-05-29 |
2018-04-11 |
Juno Therapeutics Inc |
Composition et procédés de régulation des interactions inhibitrices dans les cellules génétiquement modifiées
|
|
EP3331582A4
(en)
|
2015-05-29 |
2019-08-07 |
Agenovir Corporation |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRANSPLANTATION CELLS
|
|
EP3303634B1
(en)
*
|
2015-06-03 |
2023-08-30 |
The Regents of The University of California |
Cas9 variants and methods of use thereof
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
IL293323B2
(en)
*
|
2015-06-18 |
2024-01-01 |
Massachusetts Inst Technology |
Crispr enzyme mutations reducing off-target effects
|
|
JP7044373B2
(ja)
|
2015-07-15 |
2022-03-30 |
ラトガース，ザ ステート ユニバーシティ オブ ニュージャージー |
ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
HK1250517A1
(zh)
|
2015-09-17 |
2018-12-21 |
Novartis Ag |
增强功效的car t细胞疗法
|
|
WO2017048969A1
(en)
|
2015-09-17 |
2017-03-23 |
The Regents Of The University Of California |
Variant cas9 polypeptides comprising internal insertions
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
|
MX2018005618A
(es)
|
2015-11-05 |
2018-08-01 |
Juno Therapeutics Inc |
Receptores quimericos que contienen dominios inductores de traf y composiciones y metodos relacionados.
|
|
WO2017132580A2
(en)
|
2016-01-29 |
2017-08-03 |
The Trustees Of Princeton University |
Split inteins with exceptional splicing activity
|
|
WO2017180993A1
(en)
|
2016-04-14 |
2017-10-19 |
Bluebird Bio, Inc. |
Salvage chimeric antigen receptor systems
|
|
AU2017306557B2
(en)
|
2016-08-03 |
2023-08-03 |
Washington University |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
|
SG10201913505WA
(en)
*
|
2016-10-17 |
2020-02-27 |
Univ Nanyang Tech |
Truncated crispr-cas proteins for dna targeting
|
|
KR20240005168A
(ko)
|
2016-11-04 |
2024-01-11 |
2세븐티 바이오, 인코포레이티드 |
항-bcma car t 세포 조성물
|
|
US11180778B2
(en)
|
2016-11-11 |
2021-11-23 |
The Regents Of The University Of California |
Variant RNA-guided polypeptides and methods of use
|
|
US11192929B2
(en)
*
|
2016-12-08 |
2021-12-07 |
Regents Of The University Of Minnesota |
Site-specific DNA base editing using modified APOBEC enzymes
|
|
MY206324A
(en)
|
2016-12-08 |
2024-12-10 |
Intellia Therapeutics Inc |
Modified guide rnas
|
|
CA3048479A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Gene editing of pcsk9
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
JP7219972B2
(ja)
|
2017-01-05 |
2023-02-09 |
ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー |
Ｄｎａ二本鎖切断に非依存的な標的化遺伝子編集プラットフォームおよびその用途
|
|
WO2018152197A1
(en)
|
2017-02-15 |
2018-08-23 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
ES2992912T3
(en)
|
2017-04-21 |
2024-12-19 |
Massachusetts Gen Hospital |
Variants of cpf1 (cas12a) with altered pam specificity
|
|
US12297436B2
(en)
|
2017-05-18 |
2025-05-13 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
AU2018273986A1
(en)
|
2017-05-25 |
2019-12-12 |
The General Hospital Corporation |
Bipartite base editor (BBE) architectures and type-II-C-Cas9 zinc finger editing
|
|
US20200248169A1
(en)
|
2017-06-26 |
2020-08-06 |
The Broad Institute, Inc. |
Crispr/cas-cytidine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
CA3064601A1
(en)
*
|
2017-06-26 |
2019-01-03 |
President And Fellows Of Harvard College |
Crispr/cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
US10392616B2
(en)
|
2017-06-30 |
2019-08-27 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
CA3073448A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
AR114014A1
(es)
|
2017-12-22 |
2020-07-08 |
Inst Genetics & Developmental Biology Cas |
Sistema de edición de bases y método basado en proteína cpf1
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
CN112805379B
(zh)
|
2018-08-03 |
2024-08-20 |
比姆医疗股份有限公司 |
多效应核碱基编辑器和使用其修饰核酸靶序列的方法
|
|
US20230021641A1
(en)
|
2018-08-23 |
2023-01-26 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
|
AU2019336245B2
(en)
|
2018-09-07 |
2026-02-26 |
Beam Therapeutics Inc. |
Compositions and methods for delivering a nucleobase editing system
|
|
EP3887521A1
(en)
|
2018-11-29 |
2021-10-06 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
AU2020216484A1
(en)
|
2019-01-31 |
2021-07-29 |
Beam Therapeutics Inc. |
Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
|
|
CN114040977B
(zh)
|
2019-01-31 |
2024-09-03 |
比姆医疗股份有限公司 |
非靶脱氨反应减低的核碱基编辑器和用于定性核碱基编辑器的测定
|
|
EP3921417A4
(en)
|
2019-02-04 |
2022-11-09 |
The General Hospital Corporation |
VARIANTS OF ADENINE DNA BASES WITH REDUCED OFF-TARGET RNA EDIT
|
|
WO2020168088A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
CN119280261A
(zh)
|
2019-02-13 |
2025-01-10 |
比姆医疗股份有限公司 |
使用腺苷脱氨酶碱基编辑器编辑疾病相关基因的方法，包括遗传性疾病的治疗
|
|
CA3128881A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
AU2020223314A1
(en)
|
2019-02-13 |
2021-08-12 |
Beam Therapeutics Inc. |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
SG11202108346WA
(en)
|
2019-02-13 |
2021-08-30 |
Beam Therapeutics Inc |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
AU2020221366A1
(en)
|
2019-02-13 |
2021-08-26 |
Beam Therapeutics Inc. |
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
|
|
CA3236512C
(en)
|
2019-02-13 |
2026-02-24 |
Beam Therapeutics Inc. |
Compositions and methods for treating hemoglobinopathies
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
KR102258713B1
(ko)
|
2019-07-31 |
2021-05-31 |
한양대학교 산학협력단 |
사이토신 염기교정용 조성물 및 이의 용도
|
|
EP4028026A4
(en)
|
2019-09-09 |
2023-09-06 |
Beam Therapeutics, Inc. |
NOVEL NUCLEOBASE EDITORS AND METHODS OF USING THE SAME
|
|
KR20220061241A
(ko)
|
2019-09-17 |
2022-05-12 |
러트거즈,더스테이트유니버시티오브뉴저지 |
표적화된 게놈 변형을 위한 rna-압타머 동원에 의해 매개된 고도로 효율적인 dna 염기 편집기 및 이의 용도
|
|
KR20220110739A
(ko)
|
2019-10-30 |
2022-08-09 |
페어와이즈 플랜츠 서비시즈, 인크. |
유형 v crispr-cas 염기 편집제 및 그의 사용 방법
|
|
US20230086199A1
(en)
|
2019-11-26 |
2023-03-23 |
The Broad Institute, Inc. |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
|
EP4100519A2
(en)
|
2020-02-05 |
2022-12-14 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
EP4707398A2
(en)
|
2020-02-05 |
2026-03-11 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
|
US20230313234A1
(en)
|
2020-03-04 |
2023-10-05 |
Suzhou Qi Biodesign Biotechnology Company Limited |
Improved cytosine base editing system
|
|
AU2021236683A1
(en)
|
2020-03-19 |
2022-11-17 |
Intellia Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
WO2021207651A2
(en)
|
2020-04-09 |
2021-10-14 |
Verve Therapeutics, Inc. |
Chemically modified guide rnas for genome editing with cas12b
|
|
WO2022008935A1
(en)
|
2020-07-10 |
2022-01-13 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
CA3173949A1
(en)
|
2020-07-15 |
2022-01-20 |
LifeEDIT Therapeutics, Inc. |
Uracil stabilizing proteins and active fragments and variants thereof and methods of use
|
|
CA3192224A1
(en)
|
2020-09-11 |
2022-03-17 |
Jyun-Liang LIN |
Base editing enzymes
|
|
EP4211235A2
(en)
|
2020-09-11 |
2023-07-19 |
Lifeedit Therapeutics, Inc. |
Dna modifying enzymes and active fragments and variants thereof and methods of use
|
|
IT202000028688A1
(it)
|
2020-11-27 |
2022-05-27 |
Consiglio Nazionale Ricerche |
Varianti della citidina deaminasi per l’editazione di basi
|
|
EP4274902A4
(en)
|
2021-01-05 |
2025-04-16 |
Revvity Discovery Limited |
Guide RNA designs and complexes for tracless V-CAS systems
|
|
US20240060088A1
(en)
|
2021-01-05 |
2024-02-22 |
Horizon Discovery Limited |
Guide RNA Designs and Complexes for Type V Cas Systems
|
|
CA3207144A1
(en)
|
2021-01-05 |
2022-07-14 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
WO2022178307A1
(en)
|
2021-02-19 |
2022-08-25 |
Beam Therapeutics Inc. |
Recombinant rabies viruses for gene therapy
|
|
BR112023019539A2
(pt)
|
2021-03-26 |
2023-12-05 |
Beam Therapeutics Inc |
Variantes de adenosina desaminase e usos das mesmas
|
|
US20240327859A1
(en)
|
2021-07-02 |
2024-10-03 |
University Of Maryland, College Park |
Cytidine deaminases and methods of genome editing using the same
|
|
AU2022311013A1
(en)
|
2021-07-16 |
2024-02-08 |
President And Fellows Of Harvard College |
Context-specific adenine base editors and uses thereof
|
|
WO2023034959A2
(en)
|
2021-09-03 |
2023-03-09 |
The University Of Chicago |
Polypeptides and methods for modifying nucleic acids
|
|
GB2628238A
(en)
|
2021-09-22 |
2024-09-18 |
Verve Therapeutics Inc |
Gene editing of PCSK9 or ANGPTL3 and compositions and methods of using same for treatment of disease
|
|
WO2023047338A1
(en)
|
2021-09-24 |
2023-03-30 |
Crispr Therapeutics Ag |
PRODRUG INCORPORATED sgRNA SYNTHESIS
|
|
WO2023125814A1
(zh)
|
2021-12-29 |
2023-07-06 |
华东师范大学 |
腺嘌呤脱氨酶及其应用
|
|
EP4479436A4
(en)
|
2022-02-17 |
2026-04-15 |
Correctsequence Therapeutics |
CYTIDINE DESAMINASE MUTANTS WITH IMPROVED EDITING ACCURACY
|
|
CN117925585A
(zh)
|
2022-04-07 |
2024-04-26 |
尧唐(上海)生物科技有限公司 |
腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途
|
|
JP2025517515A
(ja)
|
2022-05-26 |
2025-06-05 |
ユーシービー バイオファルマ エスアールエル |
新規核酸編集タンパク質
|
|
EP4540378A1
(en)
|
2022-06-20 |
2025-04-23 |
CRISPR Therapeutics AG |
Base editing proteins and uses thereof
|
|
US20250369008A1
(en)
|
2022-06-23 |
2025-12-04 |
BASF Agricultural Solutions LLC |
Diversifying base editing
|
|
EP4573191A1
(en)
|
2022-08-16 |
2025-06-25 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
|
KR20250075667A
(ko)
|
2022-09-23 |
2025-05-28 |
기초과학연구원 |
신규한 아데닌 탈아미노효소 변이체 및 이를 사용한 염기 교정 방법
|
|
AU2023351206A1
(en)
|
2022-09-26 |
2025-03-20 |
Beam Therapeutics Inc. |
Synthetic polypeptides and uses thereof
|
|
WO2024179426A2
(en)
|
2023-02-28 |
2024-09-06 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Deaminases for use in base editing
|
|
EP4688814A1
(en)
|
2023-04-27 |
2026-02-11 |
University of Massachusetts |
Cas-embedded cytidine deaminase ribonucleoprotein complexes having improved base editing specificity and efficiency
|
|
CN121079412A
(zh)
|
2023-04-28 |
2025-12-05 |
比姆医疗股份有限公司 |
经修饰的指导rna
|
|
EP4728067A2
(en)
|
2023-06-15 |
2026-04-22 |
Beam Therapeutics Inc. |
Methods and compositions for treating alpha-1 antitrypsin deficiency
|
|
CN116836962B
(zh)
|
2023-06-28 |
2024-04-05 |
微光基因(苏州)有限公司 |
工程化的腺苷脱氨酶及碱基编辑器
|